Synthesis, characterization of penicillin G capped silver nanoconjugates to combat β-lactamase resistance in infectious microorganism

Journal of Biotechnology

Volumn 163, Issue 4, 2013, Pages 419-424

  Ahmed, Vasim ^a   Kumar, Jitendra ^a   Kumar, Manoj ^a   Chauhan, Manu Bhambi ^a   Vij, Manika ^b   Ganguli, Munia ^b   Chauhan, Nar Singh ^a  

^a MAHARSHI DAYANAND UNIVERSITY   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Antibiotic resistance; Nanoconjugates; Polyaniline; Silver nanoparticles

Indexed keywords

ANTIBIOTIC RESISTANCE; CARBOXYL GROUPS; E. COLI; FORMATION PROCESS; FREE AMINES; FTIR SPECTROSCOPY; FUNCTIONALIZED; GRAM POSITIVE; GROWTH INHIBITION; LACTAMASES; MONO-DISPERSED; NOVEL STRATEGIES; PENICILLIN G; SILVER NANOPARTICLES; STAPHYLOCOCCUS AUREUS; UNIFORM LAYER; UV-VIS SPECTROSCOPY;

ATOMIC FORCE MICROSCOPY; BACTERIA; ESCHERICHIA COLI; FOURIER TRANSFORM INFRARED SPECTROSCOPY; NANOCONJUGATES; NANOPARTICLES; ORGANIC ACIDS; POLYANILINE; SCANNING ELECTRON MICROSCOPY; SYNTHESIS (CHEMICAL); ULTRAVIOLET VISIBLE SPECTROSCOPY;

SILVER;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; ASCORBIC ACID; BETA LACTAM ANTIBIOTIC; PENICILLIN G; POLYANILINE; SILVER NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; ATOMIC FORCE MICROSCOPY; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; ULTRAVIOLET SPECTROSCOPY;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BIOTECHNOLOGY; ESCHERICHIA COLI; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; NANOCONJUGATES; PENICILLIN G; SILVER; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STAPHYLOCOCCUS AUREUS; X-RAY DIFFRACTION;

ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84874341522     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2012.12.002     Document Type: Article

References (30)

1. Abeylath S.C., Turos E. Drug delivery approaches to overcome bacterial resistance to beta-lactam antibiotics. Experts Opinion in Drug Delivery 2008, 5:931-949.
2. Bud R. Antibiotics: the epitome of a wonder drug. British Medical Journal 2007, 334(Suppl. 1):s6.
3. Bush K. Alarming beta-lactamase-mediated resistance in multidrug-resistant enterobacteriaceae. Current Opinion in Microbiology 2010, 13:558-564.
4. Chaloupka K., Malam Y., Seifalian A.M. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends in Biotechnology 2010, 28:580-588.
5. Cornaglia G., Giamarellou H., Rossolini G.M. Metallo-beta-lactamases: a last frontier for beta-lactams?. Lancet Infectious Diseases 2011, 11:381-393.
6. Demain A.L. Antibiotics: natural products essential to human health. Medicinal Research Reviews 2009, 29:821-842.
7. Dey S., Chaudhary R., Vaithiyanathan S. Spectrophotometric method developed for the estimation of flucloxacilin in bulk and dosage form using UV-vis spectrophotometric method. International Journal of Pharma and Biosciences 2010, 1:35-43.
8. Fircanis S., McKay M. Recognition and management of extended spectrum beta lactamase producing organisms (ESBL). Medicine Health RI 2010, 93:161-162.
9. Frezza M., Garay J., Chen D., Cui C., Turos E., Dou Q.P. Induction of tumor cell apoptosis by a novel class of N-thiolated beta-lactam antibiotics with structural modifications at N1 and C3 of the lactam ring. International Journal of Molecular Medicine 2008, 21:689-695.
10. Gniadkowski M. Evolution of extended-spectrum beta-lactamases by mutation. Clinical Microbiology and Infections 2008, 1:11-32.
11. Graham, D., Faulds, K., Smith, W.E., 2006. Biosensing using silver nanoparticles and surface enhanced resonance Raman scattering. Chemical Communications (Cambridge) 42, 4363-4371.
12. Hamilton-Miller J.M. Damaging effects of ethylenediaminetetra-acetate and penicillins on permeability barriers in gram-negative bacteria. Biochemical Journal 1966, 100:675-682.
13. Karunaratne D.N., Farmer S., Hancock R.E. Synthesis of bulky beta-lactams for inhibition of cell surface beta-lactamase activity. Bioconjugate Chemistry 1993, 4:434-439.
14. Kennedy D.C., McKay C.S., Tay L.L., Rouleau Y., Pezacki J.P. Carbon-bonded silver nanoparticles: alkyne-functionalized ligands for SERS imaging of mammalian cells. Chemical Communations (Cambridge) 2011, 47:3156-3158.
15. Lara H.H., Garza-Trevino E.N., Turrent L.I., Singh D.K. Silver Nanoparticles are broad-spectrum bactericidal and virucidal compounds. Journal of Nanobiotechnology 2011, 9:30.
16. Li W.R., Xie X.B., Shi Q.S., Zeng H.Y., Ou-Yang Y.S., Chen Y.B. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Applied Microbiology and Biotechnology 2010, 85:1115-1122.
17. 2 as an oxidant. Materials Letters 2007, 61:2011-2014.
18. Li Y., Hindi K., Watts K.M., Taylor J.B., Zhang K., Li Z., Hunstad D.A., Cannon C.L., Youngs W.J., Wooley K.L. Shell crosslinked nanoparticles carrying silver antimicrobials as therapeutics. Chemical Communications (Camb.) 2010, 46:121-123.
19. Neu H.C. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. American Journal of Medicine 1985, 79:2-13.
20. Nicolau D.P. Current challenges in the management of the infected patient. Current Opinion in Infectious Diseases 2011, 24:1-10.
21. Nottingham M., Bethel C.R., Pagadala S.R., Harry E., Pinto A., Lemons Z.A., Drawz S.M., Akker F., Carey P.R., Bonomo R.A., Buynak J.D. Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy. Bioorganic and Medicinal Chemistry Letters 2011, 21:387-393.
22. O'Callaghan C.H. Structure-activity relations and beta-lactamase resistance. Philosophical Transactions of the Royal Society London B Biological Sciences 1980, 289:197-205.
23. Pina A.S., Hussain A., Roque A.C. An historical overview of drug discovery. Methods in Molecular Biology 2009, 572:3-12.
24. Prosen K.R., Carroll R.K., Burda W.N., Krute C.N., Bhattacharya B., Dao M.L., Turos E., Shaw L.N. The impact of fatty acids on the antibacterial properties of N-thiolated beta-lactams. Bioorganic and Medicinal Chemistry Letters 2011, 21:5293.
25. Seligman S.J. Transmission of resistant bacteria in intensive care. New England Journal of Medicine 2011, 365:761-766.
26. Sondi I., Goia D.V., Matijevic E. Preparation of highly concentrated stable dispersions of uniform silver nanoparticles. Journal of Colloid Interface Science 2003, 260:75-81.
27. Sun, R.W., Chen, R., Chung, N.P., Ho, C.M., Lin, C.L., Che, C.M., 2005. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chemical Communications (Camb.) 40, 5059-5061.
28. Wei Q.S., Fu J.J.J., Shen J.C. Norvancomycin-capped silver nanoparticles: synthesis and antibacterial activities against E. coli. Science in China, Series B: Chemistry 2007, 50:418-424.
29. Weinstein L., Lerner P.I., Chew W.H. Clinical and bacteriologic studies of the effect of massive doses of penicillin G on infections caused by gram-negative Bacilli N. England Journal of Medicine 1964, 271:525-533.
30. Wilke M.H. Multiresistant bacteria and current therapy - the economical side of the story. European Journal of Medicine 2010, 15:571-576.